The UCLM-CSIC Associated Unit “Neurodeath” led by Professor Valentín Ceña, has received a two-year grant to carry out bilateral joint mobility actions with the Kaohsiung Medical University in Taiwan. This action is part of

  Through it, a new therapeutic approach for glioblastoma is developed based on using RNAi technology (more specifically siRNA) to reduce the cellular levels of proteins involved in the survival and proliferation of tumor cells.

From October 3 to 5, the XLI National Congress of Pharmacology took place in Palma de Mallorca, where advances in pharmacological and therapeutic research carried out by Spanish Pharmacologists were presented. Within the scientific program